

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * drug catabolic process (GO:0042737) | 9.86802980 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.08137888 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 9.05975096 |
| 4 | complement activation, alternative pathway (GO:0006957) | 7.80733789 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.79390396 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 7.79390396 |
| 7 | regulation of fibrinolysis (GO:0051917) | 7.72595382 |
| 8 | glyoxylate metabolic process (GO:0046487) | 7.43835646 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 7.38483367 |
| 10 | regulation of protein activation cascade (GO:2000257) | 7.01987677 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.00227667 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 7.00227667 |
| 13 | regulation of complement activation (GO:0030449) | 6.63431674 |
| 14 | oxidative demethylation (GO:0070989) | 6.38279596 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 6.29527229 |
| 16 | * drug metabolic process (GO:0017144) | 6.28051071 |
| 17 | cellular glucuronidation (GO:0052695) | 6.24230908 |
| 18 | urea metabolic process (GO:0019627) | 6.23527391 |
| 19 | uronic acid metabolic process (GO:0006063) | 5.97643262 |
| 20 | glucuronate metabolic process (GO:0019585) | 5.97643262 |
| 21 | fibrinolysis (GO:0042730) | 5.97129756 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 5.91395786 |
| 23 | negative regulation of sterol transport (GO:0032372) | 5.91395786 |
| 24 | bile acid biosynthetic process (GO:0006699) | 5.87045054 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.82538846 |
| 26 | protein carboxylation (GO:0018214) | 5.82538846 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 5.78813172 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.71235531 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 5.64754024 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.63342745 |
| 31 | ethanol oxidation (GO:0006069) | 5.55142562 |
| 32 | blood coagulation, intrinsic pathway (GO:0007597) | 5.40344968 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 5.34426126 |
| 34 | bile acid metabolic process (GO:0008206) | 5.28999990 |
| 35 | urea cycle (GO:0000050) | 5.14450294 |
| 36 | bile acid and bile salt transport (GO:0015721) | 5.09106875 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 4.96315526 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 4.96315526 |
| 39 | tryptophan catabolic process (GO:0006569) | 4.96315526 |
| 40 | S-adenosylmethionine metabolic process (GO:0046500) | 4.95161171 |
| 41 | regulation of plasminogen activation (GO:0010755) | 4.89264096 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.76988146 |
| 43 | protein activation cascade (GO:0072376) | 4.71932357 |
| 44 | glycine metabolic process (GO:0006544) | 4.65514119 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.60723948 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.60723948 |
| 47 | alkaloid metabolic process (GO:0009820) | 4.51771228 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.51384633 |
| 49 | negative regulation of hemostasis (GO:1900047) | 4.51384633 |
| 50 | ethanol metabolic process (GO:0006067) | 4.48402852 |
| 51 | phospholipid efflux (GO:0033700) | 4.47262160 |
| 52 | complement activation, classical pathway (GO:0006958) | 4.46072483 |
| 53 | imidazole-containing compound metabolic process (GO:0052803) | 4.46001804 |
| 54 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.45685233 |
| 55 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.45685233 |
| 56 | flavonoid metabolic process (GO:0009812) | 4.45652228 |
| 57 | complement activation (GO:0006956) | 4.44685341 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.36505365 |
| 59 | protein-lipid complex remodeling (GO:0034368) | 4.29053621 |
| 60 | macromolecular complex remodeling (GO:0034367) | 4.29053621 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 4.29053621 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.28083011 |
| 63 | arginine metabolic process (GO:0006525) | 4.27016915 |
| 64 | opsonization (GO:0008228) | 4.24634327 |
| 65 | regulation of humoral immune response (GO:0002920) | 4.22812237 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 4.20171014 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 4.15808333 |
| 68 | cytolysis (GO:0019835) | 4.12777651 |
| 69 | tryptophan metabolic process (GO:0006568) | 4.12743359 |
| 70 | negative regulation of coagulation (GO:0050819) | 4.08494388 |
| 71 | acute-phase response (GO:0006953) | 4.05974685 |
| 72 | alpha-amino acid catabolic process (GO:1901606) | 4.01212525 |
| 73 | negative regulation of wound healing (GO:0061045) | 3.98561892 |
| 74 | cholesterol efflux (GO:0033344) | 3.97556092 |
| 75 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.96945880 |
| 76 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.96945880 |
| 77 | heme transport (GO:0015886) | 3.89709686 |
| 78 | intestinal cholesterol absorption (GO:0030299) | 3.88006659 |
| 79 | reverse cholesterol transport (GO:0043691) | 3.87729077 |
| 80 | negative regulation of protein activation cascade (GO:2000258) | 3.84077489 |
| 81 | hormone catabolic process (GO:0042447) | 3.82719306 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 3.82512944 |
| 83 | ketone body metabolic process (GO:1902224) | 3.80343758 |
| 84 | drug transmembrane transport (GO:0006855) | 3.77506669 |
| 85 | positive regulation of hemostasis (GO:1900048) | 3.76529801 |
| 86 | positive regulation of blood coagulation (GO:0030194) | 3.76529801 |
| 87 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.73527798 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.71555755 |
| 89 | glutamate metabolic process (GO:0006536) | 3.65972790 |
| 90 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.64378890 |
| 91 | regulation of cholesterol esterification (GO:0010872) | 3.57290881 |
| 92 | * xenobiotic metabolic process (GO:0006805) | 3.56985947 |
| 93 | arginine catabolic process (GO:0006527) | 3.56647526 |
| 94 | sodium-independent organic anion transport (GO:0043252) | 3.53502118 |
| 95 | cysteine metabolic process (GO:0006534) | 3.48282244 |
| 96 | positive regulation of coagulation (GO:0050820) | 3.43221877 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 3.42866249 |
| 98 | amino acid salvage (GO:0043102) | 3.35415552 |
| 99 | L-methionine biosynthetic process (GO:0071265) | 3.35415552 |
| 100 | * exogenous drug catabolic process (GO:0042738) | 10.7515671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.35753858 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.42687068 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.81545604 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.93717860 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.90334068 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.69365011 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.08260616 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.87042598 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.37451540 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.19969565 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07737587 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.88101077 |
| 13 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.84898953 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77877390 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76136753 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.67825401 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58141732 |
| 18 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.55520284 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44499868 |
| 20 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44378491 |
| 21 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.44317891 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32142376 |
| 23 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.32050910 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27806310 |
| 25 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27440967 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24733963 |
| 27 | AR_20517297_ChIP-Seq_VCAP_Human | 1.24333515 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.17650078 |
| 29 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.15935462 |
| 30 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14511193 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13806629 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13123313 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13105204 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11739280 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08619834 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07693515 |
| 37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07365917 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06551095 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04168192 |
| 40 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01940259 |
| 41 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01921923 |
| 42 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.01854760 |
| 43 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.97751138 |
| 44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.97744992 |
| 45 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97532419 |
| 46 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97284411 |
| 47 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.97113583 |
| 48 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.96986908 |
| 49 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96838585 |
| 50 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96688606 |
| 51 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96688606 |
| 52 | CBP_21632823_ChIP-Seq_H3396_Human | 0.94943520 |
| 53 | NCOR_22424771_ChIP-Seq_293T_Human | 0.94349154 |
| 54 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94314858 |
| 55 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93849944 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93644177 |
| 57 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.93610950 |
| 58 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.93539674 |
| 59 | NFYA_21822215_ChIP-Seq_K562_Human | 0.92956440 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92745594 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.92346965 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92346965 |
| 63 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.91568188 |
| 64 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.91568188 |
| 65 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90606462 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.90203052 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89598076 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.89153487 |
| 69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88991432 |
| 70 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.88572250 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87664904 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86724628 |
| 73 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.86238235 |
| 74 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.86223642 |
| 75 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85635015 |
| 76 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84192913 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84113934 |
| 78 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.83188120 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83020030 |
| 80 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82621100 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82345527 |
| 82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.81974504 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81140763 |
| 84 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.80929265 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80596452 |
| 86 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.80408131 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79136176 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.78760590 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77624600 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77376167 |
| 91 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.77141106 |
| 92 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.76822113 |
| 93 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76205799 |
| 94 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.76113173 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.75544302 |
| 96 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.75176326 |
| 97 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.73924405 |
| 98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.72946306 |
| 99 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.72880769 |
| 100 | NFYB_21822215_ChIP-Seq_K562_Human | 0.71177269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.56789097 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.45707825 |
| 3 | MP0005360_urolithiasis | 6.34355247 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.81328104 |
| 5 | MP0005365_abnormal_bile_salt | 5.69231499 |
| 6 | MP0003195_calcinosis | 5.62334365 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.58335211 |
| 8 | MP0003252_abnormal_bile_duct | 4.38331932 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.05582064 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.85905187 |
| 11 | MP0003868_abnormal_feces_composition | 2.55831182 |
| 12 | MP0005332_abnormal_amino_acid | 2.51141789 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.20796213 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.18290124 |
| 15 | MP0009697_abnormal_copulation | 2.08858350 |
| 16 | MP0009840_abnormal_foam_cell | 2.06833541 |
| 17 | MP0000609_abnormal_liver_physiology | 1.68964247 |
| 18 | MP0001764_abnormal_homeostasis | 1.64365661 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.60402816 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.55097769 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.41842251 |
| 22 | MP0005670_abnormal_white_adipose | 1.37383391 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.32121306 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.12418490 |
| 25 | MP0008872_abnormal_physiological_respon | 1.11773091 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.06140629 |
| 27 | MP0002132_abnormal_respiratory_system | 1.03940044 |
| 28 | MP0001661_extended_life_span | 1.01158747 |
| 29 | MP0009764_decreased_sensitivity_to | 0.99985467 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92912852 |
| 31 | MP0005408_hypopigmentation | 0.88423919 |
| 32 | MP0009053_abnormal_anal_canal | 0.87398657 |
| 33 | MP0003011_delayed_dark_adaptation | 0.85999574 |
| 34 | MP0000598_abnormal_liver_morphology | 0.85578397 |
| 35 | MP0009642_abnormal_blood_homeostasis | 0.80570534 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 0.79941511 |
| 37 | MP0002971_abnormal_brown_adipose | 0.77919180 |
| 38 | MP0009763_increased_sensitivity_to | 0.77832181 |
| 39 | MP0005376_homeostasis/metabolism_phenot | 0.76621712 |
| 40 | MP0003186_abnormal_redox_activity | 0.75438748 |
| 41 | MP0008469_abnormal_protein_level | 0.74550405 |
| 42 | MP0003879_abnormal_hair_cell | 0.73738278 |
| 43 | MP0002282_abnormal_trachea_morphology | 0.72779770 |
| 44 | MP0005395_other_phenotype | 0.70802075 |
| 45 | MP0004043_abnormal_pH_regulation | 0.69912759 |
| 46 | MP0003638_abnormal_response/metabolism_ | 0.69177398 |
| 47 | MP0002168_other_aberrant_phenotype | 0.68016650 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 0.65171712 |
| 49 | MP0005187_abnormal_penis_morphology | 0.64237156 |
| 50 | MP0005266_abnormal_metabolism | 0.63162187 |
| 51 | MP0005535_abnormal_body_temperature | 0.60918485 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 0.59252037 |
| 53 | MP0005448_abnormal_energy_balance | 0.58839962 |
| 54 | MP0003690_abnormal_glial_cell | 0.55391063 |
| 55 | MP0009785_altered_susceptibility_to | 0.54182106 |
| 56 | MP0005334_abnormal_fat_pad | 0.53383351 |
| 57 | MP0000604_amyloidosis | 0.52681761 |
| 58 | MP0005646_abnormal_pituitary_gland | 0.51477316 |
| 59 | MP0003718_maternal_effect | 0.49827037 |
| 60 | MP0001986_abnormal_taste_sensitivity | 0.49714322 |
| 61 | MP0002249_abnormal_larynx_morphology | 0.49446599 |
| 62 | MP0003646_muscle_fatigue | 0.48116971 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.45672176 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.45592439 |
| 65 | MP0004130_abnormal_muscle_cell | 0.44723383 |
| 66 | MP0004133_heterotaxia | 0.44089720 |
| 67 | MP0002136_abnormal_kidney_physiology | 0.43669124 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 0.43391686 |
| 69 | MP0005166_decreased_susceptibility_to | 0.42038132 |
| 70 | MP0008874_decreased_physiological_sensi | 0.41900608 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.40640592 |
| 72 | MP0004142_abnormal_muscle_tone | 0.40334191 |
| 73 | MP0002928_abnormal_bile_duct | 0.39943995 |
| 74 | MP0002102_abnormal_ear_morphology | 0.39615508 |
| 75 | MP0004883_abnormal_blood_vessel | 0.37097345 |
| 76 | MP0000249_abnormal_blood_vessel | 0.35200865 |
| 77 | MP0001756_abnormal_urination | 0.34334217 |
| 78 | MP0005451_abnormal_body_composition | 0.34285124 |
| 79 | MP0002254_reproductive_system_inflammat | 0.34246824 |
| 80 | MP0003953_abnormal_hormone_level | 0.34120692 |
| 81 | MP0004147_increased_porphyrin_level | 0.33794492 |
| 82 | MP0001915_intracranial_hemorrhage | 0.29803093 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.29606714 |
| 84 | MP0005647_abnormal_sex_gland | 0.29015608 |
| 85 | MP0000467_abnormal_esophagus_morphology | 0.28124425 |
| 86 | MP0001984_abnormal_olfaction | 0.28040575 |
| 87 | MP0000566_synostosis | 0.27943208 |
| 88 | MP0003075_altered_response_to | 0.27644033 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.27573392 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.27510567 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.27079071 |
| 92 | MP0009745_abnormal_behavioral_response | 0.26680444 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.26555390 |
| 94 | MP0001663_abnormal_digestive_system | 0.26319119 |
| 95 | MP0005164_abnormal_response_to | 0.25643713 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 0.24810011 |
| 97 | MP0003878_abnormal_ear_physiology | 0.24738847 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.24738847 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.24111064 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.24064541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.78856859 |
| 2 | Complement deficiency (HP:0004431) | 9.22406944 |
| 3 | Deep venous thrombosis (HP:0002625) | 8.81816004 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 8.68918869 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 7.78381714 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.61059620 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 7.33319103 |
| 8 | Abnormality of complement system (HP:0005339) | 7.26588087 |
| 9 | Joint hemorrhage (HP:0005261) | 5.98065100 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 5.89077429 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 5.65985233 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.58084160 |
| 13 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.18710410 |
| 14 | Xanthomatosis (HP:0000991) | 5.18178967 |
| 15 | Glomerulonephritis (HP:0000099) | 4.68842932 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.27520512 |
| 17 | Spontaneous abortion (HP:0005268) | 4.21633138 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.04802881 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.03029179 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81897010 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.81447835 |
| 22 | Nephritis (HP:0000123) | 3.67082735 |
| 23 | Fat malabsorption (HP:0002630) | 3.64199175 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.57084700 |
| 25 | Hyperglycinemia (HP:0002154) | 3.52128614 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.35144503 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.35144503 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.22298577 |
| 29 | Hyperglycinuria (HP:0003108) | 3.19934662 |
| 30 | Delayed CNS myelination (HP:0002188) | 3.19186552 |
| 31 | Hyperammonemia (HP:0001987) | 3.17024970 |
| 32 | Vascular calcification (HP:0004934) | 3.06648055 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.92775317 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.88197790 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.87964154 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 2.80310247 |
| 37 | Mitral stenosis (HP:0001718) | 2.80301670 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 2.79391563 |
| 39 | Steatorrhea (HP:0002570) | 2.77351915 |
| 40 | Rickets (HP:0002748) | 2.76131269 |
| 41 | Epidermoid cyst (HP:0200040) | 2.71657405 |
| 42 | Hypercholesterolemia (HP:0003124) | 2.70991131 |
| 43 | Hemorrhage of the eye (HP:0011885) | 2.66122496 |
| 44 | Cardiovascular calcification (HP:0011915) | 2.64984098 |
| 45 | Hyperbilirubinemia (HP:0002904) | 2.59558222 |
| 46 | Gingival bleeding (HP:0000225) | 2.53041152 |
| 47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.51756128 |
| 48 | Fair hair (HP:0002286) | 2.49069321 |
| 49 | Metabolic acidosis (HP:0001942) | 2.47424706 |
| 50 | Abnormality of vitamin metabolism (HP:0100508) | 2.42569930 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 2.38116591 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.38116591 |
| 53 | Thrombophlebitis (HP:0004418) | 2.35502289 |
| 54 | Arthropathy (HP:0003040) | 2.28475989 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.22958324 |
| 56 | Glycosuria (HP:0003076) | 2.22958324 |
| 57 | Ketosis (HP:0001946) | 2.22259019 |
| 58 | Neonatal hypoglycemia (HP:0001998) | 2.21746691 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.21364963 |
| 60 | Osteomalacia (HP:0002749) | 2.20689475 |
| 61 | Pulmonary embolism (HP:0002204) | 2.20570304 |
| 62 | Bile duct proliferation (HP:0001408) | 2.18731743 |
| 63 | Abnormal biliary tract physiology (HP:0012439) | 2.18731743 |
| 64 | Hypophosphatemic rickets (HP:0004912) | 2.11665117 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.06354796 |
| 66 | Alkalosis (HP:0001948) | 2.04100820 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.02298946 |
| 68 | Joint swelling (HP:0001386) | 1.99599020 |
| 69 | Purpura (HP:0000979) | 1.97040337 |
| 70 | Irritability (HP:0000737) | 1.96515748 |
| 71 | Cerebral palsy (HP:0100021) | 1.94877259 |
| 72 | Lethargy (HP:0001254) | 1.92822307 |
| 73 | Menorrhagia (HP:0000132) | 1.84923603 |
| 74 | Cholelithiasis (HP:0001081) | 1.83878966 |
| 75 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82920097 |
| 76 | Pancreatitis (HP:0001733) | 1.81772244 |
| 77 | Generalized hypopigmentation of hair (HP:0011358) | 1.78618035 |
| 78 | Bifid scrotum (HP:0000048) | 1.77913888 |
| 79 | Gangrene (HP:0100758) | 1.76796238 |
| 80 | Abnormality of iron homeostasis (HP:0011031) | 1.76507838 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 1.75915049 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 1.71043506 |
| 83 | Increased serum pyruvate (HP:0003542) | 1.70304348 |
| 84 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.68727913 |
| 85 | Elevated alkaline phosphatase (HP:0003155) | 1.68407028 |
| 86 | Poikilocytosis (HP:0004447) | 1.68292592 |
| 87 | Increased serum ferritin (HP:0003281) | 1.65189335 |
| 88 | Enlarged kidneys (HP:0000105) | 1.64646928 |
| 89 | Hypochromic microcytic anemia (HP:0004840) | 1.63238882 |
| 90 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.62315113 |
| 91 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.61995128 |
| 92 | Abnormality of alanine metabolism (HP:0010916) | 1.61995128 |
| 93 | Hyperalaninemia (HP:0003348) | 1.61995128 |
| 94 | Cerebral edema (HP:0002181) | 1.59739137 |
| 95 | Abnormal urine phosphate concentration (HP:0012599) | 1.55800789 |
| 96 | Myocardial infarction (HP:0001658) | 1.53590463 |
| 97 | Nephrolithiasis (HP:0000787) | 1.45822974 |
| 98 | Blue irides (HP:0000635) | 1.43499175 |
| 99 | Late onset (HP:0003584) | 1.42708046 |
| 100 | Potter facies (HP:0002009) | 1.40136951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.30782458 |
| 2 | MAP4K2 | 3.36220001 |
| 3 | TAOK2 | 3.26434003 |
| 4 | TLK1 | 3.03748600 |
| 5 | ERN1 | 2.84928960 |
| 6 | PINK1 | 2.84028126 |
| 7 | TAOK3 | 2.77299248 |
| 8 | PIK3CA | 2.73897247 |
| 9 | ADRBK2 | 2.57785593 |
| 10 | WNK3 | 2.52362629 |
| 11 | PIK3CG | 2.44483350 |
| 12 | MAP2K6 | 2.36801061 |
| 13 | WNK4 | 2.32188988 |
| 14 | ACVR1B | 2.22914908 |
| 15 | BCKDK | 2.12227741 |
| 16 | GRK1 | 2.05451394 |
| 17 | DAPK2 | 1.80052957 |
| 18 | INSRR | 1.78735331 |
| 19 | MAPKAPK3 | 1.66842774 |
| 20 | PRKAA2 | 1.62366495 |
| 21 | CASK | 1.56568059 |
| 22 | SIK2 | 1.56107382 |
| 23 | PRKCG | 1.54920047 |
| 24 | EPHA3 | 1.43633001 |
| 25 | NTRK3 | 1.34751108 |
| 26 | * PRKACG | 1.34051878 |
| 27 | MAP3K5 | 1.27922259 |
| 28 | OXSR1 | 1.27039190 |
| 29 | TIE1 | 1.25782136 |
| 30 | NLK | 1.24584692 |
| 31 | STK39 | 1.23907932 |
| 32 | MAP2K4 | 1.19568313 |
| 33 | MUSK | 1.17870799 |
| 34 | ERBB2 | 1.17377846 |
| 35 | RIPK1 | 1.15648478 |
| 36 | MAPK11 | 1.14773459 |
| 37 | IGF1R | 1.09565579 |
| 38 | SIK1 | 1.06630908 |
| 39 | BMPR1B | 1.04831620 |
| 40 | PRKCZ | 0.96935416 |
| 41 | BCR | 0.96236500 |
| 42 | TNK2 | 0.91917866 |
| 43 | NUAK1 | 0.89525247 |
| 44 | TNIK | 0.87888711 |
| 45 | TXK | 0.85775539 |
| 46 | FGFR4 | 0.82808965 |
| 47 | PRKACA | 0.82269921 |
| 48 | MST1R | 0.81084058 |
| 49 | PRKAA1 | 0.78328869 |
| 50 | PAK3 | 0.76302241 |
| 51 | PRKCE | 0.75408444 |
| 52 | TYK2 | 0.74770522 |
| 53 | MAP3K4 | 0.71732229 |
| 54 | PRKCQ | 0.71606751 |
| 55 | FER | 0.71303785 |
| 56 | MAPK13 | 0.70545142 |
| 57 | PRKG1 | 0.70087728 |
| 58 | PRKCA | 0.69859339 |
| 59 | MAP3K11 | 0.69225691 |
| 60 | NME1 | 0.66237693 |
| 61 | ADRBK1 | 0.65721745 |
| 62 | IKBKB | 0.63161032 |
| 63 | CAMKK2 | 0.62451874 |
| 64 | ZAK | 0.62340645 |
| 65 | DYRK2 | 0.61893115 |
| 66 | CSNK1A1 | 0.61408988 |
| 67 | MAP3K12 | 0.59561625 |
| 68 | TBK1 | 0.58781833 |
| 69 | EPHA4 | 0.58554741 |
| 70 | STK11 | 0.58093307 |
| 71 | CSNK1D | 0.58089400 |
| 72 | MAP2K2 | 0.57964236 |
| 73 | KDR | 0.57053863 |
| 74 | CHUK | 0.53006598 |
| 75 | MAPK15 | 0.51429013 |
| 76 | ITK | 0.50055352 |
| 77 | PDPK1 | 0.49785299 |
| 78 | PRKCB | 0.49312211 |
| 79 | STK38L | 0.45617313 |
| 80 | ABL2 | 0.44863222 |
| 81 | BRSK2 | 0.43837892 |
| 82 | MAPK7 | 0.40344276 |
| 83 | PDK1 | 0.39825657 |
| 84 | MET | 0.39193887 |
| 85 | JAK1 | 0.37444918 |
| 86 | MAP2K7 | 0.37249684 |
| 87 | CSNK1G1 | 0.35838432 |
| 88 | IKBKE | 0.35306719 |
| 89 | CSNK2A1 | 0.35120212 |
| 90 | CSF1R | 0.33281326 |
| 91 | PRKG2 | 0.33206860 |
| 92 | PRKACB | 0.32380433 |
| 93 | MAP3K2 | 0.32096627 |
| 94 | RPS6KA3 | 0.31249298 |
| 95 | FGFR2 | 0.29993571 |
| 96 | MAP3K7 | 0.27164968 |
| 97 | MAP2K1 | 0.26812485 |
| 98 | KIT | 0.26447573 |
| 99 | ABL1 | 0.26296326 |
| 100 | JAK2 | 0.25170114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.65159089 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.18507129 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.72466955 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.57764574 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44542976 |
| 6 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.37251108 |
| 7 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.30552343 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.99846346 |
| 9 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.76498784 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.66938552 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.65368711 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58002426 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.57230789 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43631521 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30134871 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28814867 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.21625161 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.20877488 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.09959432 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.07074192 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06816891 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93999806 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.79920232 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.73290194 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56483378 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.55637258 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48308763 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48010087 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39387992 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37623979 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.33382059 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31244816 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30382594 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.27413661 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26995558 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21964082 |
| 37 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.16910945 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.07952150 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05653428 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02678621 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96787814 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 0.96720131 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95392965 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94863475 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93554928 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92593950 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92484291 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88162750 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86067761 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80319196 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75034765 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67185387 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64851421 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59399144 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56795298 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56370900 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53828828 |
| 58 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47459922 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41819421 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37352883 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.37265577 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36898091 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32683317 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.27220192 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26928457 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.20184162 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.15171443 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14544036 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.14034891 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.12854932 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.11353639 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.10630727 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.09759995 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09720502 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06661811 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.05093582 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02657266 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | -0.1773904 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1769372 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | -0.1762444 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1695922 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1560269 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1516601 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1370559 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | -0.1274294 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1194751 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1160772 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1128101 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.1101032 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0783875 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0687576 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0636422 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0564604 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0519544 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.0486738 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0382118 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0375502 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0368880 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0367143 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0325103 |

